Senestech (NASDAQ:SNES) Major Shareholder Glenbrook Capital Management Acquires 42,739 Shares

Senestech, Inc. (NASDAQ:SNES) major shareholder Glenbrook Capital Management bought 42,739 shares of the company’s stock in a transaction dated Monday, February 2nd. The stock was bought at an average price of $1.98 per share, with a total value of $84,623.22. Following the acquisition, the insider owned 593,785 shares in the company, valued at approximately $1,175,694.30. This trade represents a 7.76% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Major shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Glenbrook Capital Management also recently made the following trade(s):

• On Friday, January 30th, Glenbrook Capital Management acquired 5,399 shares of Senestech stock. The shares were purchased at an average cost of $1.87 per share, with a total value of $10,096.13.

Senestech Trading Down 7.4%

Shares of SNES traded down $0.15 during midday trading on Tuesday, hitting $1.88. The stock had a trading volume of 70,832 shares, compared to its average volume of 42,879. Senestech, Inc. has a 1 year low of $1.30 and a 1 year high of $6.24. The firm has a market cap of $9.81 million, a PE ratio of -0.52 and a beta of 0.22. The company has a debt-to-equity ratio of 0.01, a current ratio of 15.75 and a quick ratio of 14.73. The stock’s 50 day moving average is $2.35 and its 200 day moving average is $3.61.

Senestech (NASDAQ:SNES) last released its quarterly earnings results on Monday, November 10th. The company reported ($0.28) EPS for the quarter, topping analysts’ consensus estimates of ($0.35) by $0.07. Senestech had a negative net margin of 253.54% and a negative return on equity of 98.35%. The firm had revenue of $0.69 million during the quarter, compared to analysts’ expectations of $0.73 million. As a group, analysts forecast that Senestech, Inc. will post -10.22 EPS for the current fiscal year.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Senestech in a research note on Monday, December 29th. One analyst has rated the stock with a Strong Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold”.

Hedge Funds Weigh In On Senestech

A number of institutional investors have recently modified their holdings of SNES. Sabby Management LLC bought a new stake in shares of Senestech during the third quarter valued at approximately $313,000. Corsair Capital Management L.P. purchased a new position in Senestech during the 2nd quarter worth $255,000. Jane Street Group LLC bought a new stake in Senestech during the 2nd quarter valued at $161,000. Millennium Management LLC purchased a new stake in shares of Senestech in the 3rd quarter worth $126,000. Finally, Essex Investment Management Co. LLC purchased a new stake in shares of Senestech in the 3rd quarter worth $115,000. 5.19% of the stock is owned by hedge funds and other institutional investors.

About Senestech

SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.

The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.